[Reactogenicity, safety and immunogenicity of a recombinant bivaccine against smallpox and hepatitis B in limited clinical trials].
Sergeev AA, Sergeev AN, Petrishchenko VA, Shishkina LN, Kochneva GV, Zhukov VA, Evtin NK, P'iankov OV, Sandakhchiev LS, Akinfeeva LA, Udut VV, Sherstoboev EIu, Gol'dberg ED, Mel'nikov SA, Podkuĭko VN, Maksimov VA.
Sergeev AA, et al.
Vopr Virusol. 2004 Sep-Oct;49(5):22-6.
Vopr Virusol. 2004.
PMID: 15529859
Clinical Trial.
Russian.